Sort
16,300 grants matching “fatty liver disease”
Genetics of Cardiometabolic Diseases in the VA Population
$0Philip S Tsao · Veterans Admin Palo Alto Health Care Sys · I01 · FY2022 · VA
Ectopic Lipid in Skeletal Muscle is Associated with Glucose Intolerance in Veterans with HIV
$0Heidi Jaye Silver · Veterans Health Administration · I01 · FY2022 · VA
Roles of Sphingolipids in the Pathophysiology of Obesity and Diabetes
$0Lauren Ashley Cowart · Ralph H Johnson Va Medical Center · I01 · FY2014 · VA
Role of non-genomic regulation of mitochondrial trifunctional protein in NAFLD
$0Jamal A Ibdah · Harry S. Truman Memorial Va Hospital · I01 · FY2022 · VA
BLR&D Research Career Scientist Award application
$0Huang-Ge Zhang · Louisville Va Medical Medical Center · IK6 · FY2018 · VA
Regulation/Role of AcylCer in Normal Epidermis and Atopic Dermatitis
$0Peter M Elias · Veterans Affairs Med Ctr San Francisco · I01 · FY2012 · VA
Lipid Transport, Bile Acid Synthesis, and Cholesterol Homeostasis
$0William M Pandak · Va Veterans Administration Hospital · I01 · FY2011 · VA
Regulation of Metabolism by Dietary Sterols
$0Shailendra Bhanubhai Patel · Clement J. Zablocki Va Medical Center · I01 · FY2011 · VA
Mitochondrial-targeted CoQ analogs: Bioenergetic Effects in Obesity
$0William Irving Sivitz · Iowa City Va Medical Center · I01 · FY2014 · VA
NAFLD in T2DM: Prevalence in Hispanics and Role of Treatment
$0Kenneth Cusi · Veterans Health Administration · I01 · FY2013 · VA
Complement Factor H-based Therapeutic Strategies in Macular Degeneration
$0Baerbel Rohrer · Ralph H Johnson Va Medical Center · I01 · FY2022 · VA
Lipolysis
$0Fredric B. Kraemer · Veterans Admin Palo Alto Health Care Sys · I01 · FY2009 · VA
Mechanisms of Renal Lipotoxicity and Injury in Obesity and Diabetes
$0Jesus H. Dominguez · Rlr Va Medical Center · I01 · FY2009 · VA
Pyruvate Dehydrogenase kinase as Therapeutic Target for Hepatic Steatosis, Obesit
$0Robert A Harris · Rlr Va Medical Center · I01 · FY2012 · VA
Luminal Factors Affecting Duodenal Protection and Chemosensing
$0Jonathan D. Kaunitz · Va Greater Los Angeles Healthcare System · I01 · FY2024 · VA
Liver Inflammation and Injury: Molecular Mechanisms
$0Mario Chojkier · Va San Diego Healthcare System · I01 · FY2014 · VA
Hepatic eNOS in the regulation of NASH
$0Randy Scott Rector · Harry S. Truman Memorial Va Hospital · I01 · FY2024 · VA
Immunologic memory to metabolic cycling
$0Alyssa H Hasty · Veterans Health Administration · I01 · FY2022 · VA
Molecular Mechanisms of Stellate Cell Activation in Liver Fibrosis
$0Hidekazu Tsukamoto · Va Greater Los Angeles Healthcare System · I01 · FY2022 · VA
BLR&D Research Career Scientist Award Application
$0Huiping Rose Zhou · Va Veterans Administration Hospital · IK6 · FY2019 · VA
Catestatin improves glucose homeostasis and insulin sensitivity in diet-induced obese mice
$0Sushil K Mahata · Va San Diego Healthcare System · I01 · FY2019 · VA
DCLK1 is a Novel Molecular Target in Hepatocellular Carcinoma
$0Courtney Wayne Houchen · Oklahoma City Va Medical Center · I01 · FY2019 · VA
Impaired methylation alters lipid droplet dynamics in liver and adipose tissue: Role in hepatic steatosis
$0Kusum K. Kharbanda · Omaha Va Medical Center · I01 · FY2019 · VA
Interrelationship between the GH-axis and metabolism
$0Rhonda D. Kineman · Jesse Brown Va Medical Center · I01 · FY2014 · VA
Cellular Mechanisms for Increased Gluconeogenesis in Type 2 Diabetes
$0Varman T Samuel · Va Connecticut Healthcare System · I01 · FY2013 · VA